William Whalen

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 298 citations · Full text

Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States

Jennifer E. Flythe, Magdalene M. Assimon, Matthew J. Tugman et al. · American Journal of Kidney Diseases · 2020 · 231 citations · Full text

Hemodialysis, Intensive Care Units, Medicine +10

A Mutation in the Schizosaccharomyces pombe rae1 Gene Causes Defects in Poly(A)+ RNA Export and in the Cytoskeleton

Julie A. Brown, Anekella Bharathi, Anil K. Ghosh et al. · Journal of Biological Chemistry · 1995 · 152 citations · Full text

An antitermination protein engages the elongating transcription apparatus at a promoter-proximal recognition site

Sailen Barik, Balaram Ghosh, William Whalen et al. · Cell · 1987 · 128 citations

Chromatin, Transcriptional Regulation, Protein Expression +12

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 123 citations · Full text

Vaccination, Open-label Phase 1, Vaccine Target +10